Incidence rates of malignancies and hospitalized infectious events in patients with psoriasis with or without treatment and a general population in the U.S.A.: 2005-09

Comparative safety of infliximab and etanercept on the risk of serious infections: does the association vary by patient characteristics?

(2012) Sengwee Toh et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Use of a disease risk score to compare serious infections associated with anti-tumor necrosis factor therapy among high- versus lower-risk rheumatoid arthritis patients

(2012) Jeffrey R. Curtis et al.   ARTHRITIS CARE & RESEARCH

Initiation of Tumor Necrosis Factor-α Antagonists and the Risk of Hospitalization for Infection in Patients With Autoimmune Diseases

(2011) Carlos G. Grijalva et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Identification of Patients With Nonmelanoma Skin Cancer Using Health Maintenance Organization Claims Data

(2009) M. J. Eide et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Treatments for psoriasis and the risk of malignancy

(2009) Rita V. Patel et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Psoriasis comorbidities

(2008) Alice B. Gottlieb et al.   JOURNAL OF DERMATOLOGICAL TREATMENT

Guidelines of care for the management of psoriasis and psoriatic arthritis

(2008) Alan Menter et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: Results from NHANES 2003-2004

(2008) Shanu Kohli Kurd et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY